⌘K

Login Start Free

Home/Filings/4/0001615774-18-005236

4//SEC Filing

GRANGE DAVID L 4

Accession 0001615774-18-005236

CIK 0001430306other

View on SEC.gov Company Profile

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 5:17 PM ET

Size

5.3 KB

Accession

0001615774-18-005236

Insider Transaction Report

Form 4

Period: 2018-06-12

Tonix Pharmaceuticals Holding Corp.TNXP

Director

Transactions

Award
Stock Option
2018-06-12+20,000→ 20,000 total
Exercise: $4.25From: 2019-06-12Exp: 2028-06-12→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan.

Documents

1 file

4
s110817_form4.xmlPrimary
4

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1

filerCIK 0001264908

Filing Metadata

Form type: 4
Filed: Jun 12, 8:00 PM ET
Accepted: Jun 13, 5:17 PM ET
Size: 5.3 KB

View on SEC.gov